|
|
42
|
|
|
4181BY
|
|
|
KESIMPTA 20MG INJ (NVS) OFATUMUMAB
|
|
|
OFATUMUMAB
|
|
|
KESIMPTA
|
|
|
0.4ML VIAL
|
|
|
BQ
|
|
|
3,794.29
|
|
|
3,794.29
|
|
|
20MG
|
|
|
VIAL
|
|
|
0
|
|
|
VIAL
|
|
|
NVS
|
|
|
NOVARTIS CARIBE SA
|
|
|
COL
|
|
|
AVENTA BARBADOS
|
|
|
|
|
|
|
|
|
2026-04-01
|
|
|
2028-03-31
|
|
|
No
|
|
|
No
|
|
|
|
|
|
0
|
|
|
N
|
|
|
1000
|
|
|
ANTINEOPLASTICS
|
|
|
|
|
|
SC
|
|
|
0
|
|
|
ANTINEOPLASTICS
|
|
|
|